Drug Trial Radar · NCT06418178
Dose Optimization of MDMA-Assisted Therapy for PTSD
Last checked: Nov 20, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jun 3, 2025
Primary completion
Oct 2029
Study completion Oct 2029
Sponsor
- Lead sponsor
- Bronx VA Medical CenterFederal agency
- Sponsor type
- Federal agency
- First posted
- May 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open label, within-subjects dose optimization trial will investigate the optimal number of MDMA-Assisted Therapy treatment cycles (i.e., one MDMA session and three integration sessions) in a sample of U.S. veterans with PTSD. Participants will complete from one to five cycles of MDMA-AT.
Conditions
- Posttraumatic Stress Disorder
Interventions
MidomafetamineDrug
One to five MDMA-assisted therapy sessions, each followed by three non-drug psychotherapy sessions (see behavioral intervention below)
PsychotherapyBehavioral
Standardized psychotherapy performed by therapy team
Primary outcomes
What the sponsor says the trial is designed to measure.
- PTSD Checklist for DSM-5 (PCL-5)Time frame: From Baseline to Outcome Site Visit (up to ~27 weeks for participants who complete all five treatment cycles)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
James J. Peters VA Medical Center
The Bronx, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.